Alizarine complexone dihydrate, min 97%, pa, 10 g, emballage verre

4-(3-HYDROXYOXETAN-3-YL)BENZOIC ACID, 95.0%, 250mg

(E)-1-(2,4-Dichlorophenyl)-3-(dimethylamino)prop-2-en-1-one, 98%, 1g

1-(4-piperidinyl)ethanol hydrobromide, 95.0%, 5g

tert-Butyl 3-amino-3-cyanopyrrolidine-1-carboxylate, 95.0%, 250mg

2-(5-Nitropyridin-2-yl)-1,2,3,4-tetrahydroisoquinoline, 97.0%, 100mg

3-Methoxybenzoyl chloride, 95.0%, 1g

N-Hexadécyl-N,N-diméthyl-3-ammonio-1-propane sulfonate, 5 g

(S)-tert-Butyl 2-(methoxy(methyl)carbamoyl)pyrrolidine-1-carboxylate, 95.0%, 1g

1-(Oxazol-2-yl)ethanone, 95.0%, 250mg

2-(4-Bromophenyl)pyrrolidine>95.0%(GC)(T)200mg

3-Cyano-4-isopropoxybenzoic acid, 95.0%, 250mg

3-(1H-pyrazol-1-yl)propanoic acid hydrochloride, 95.0%, 25g